General 31 May 2026 Daily Monitor (Uganda)
J&J drug reduces risk of prostate cancer spread and death in late-stage study
8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/j-j-drug-reduces-risk-of-prostate-cancer-spread-and-death-in-late-stage-study-5480024
8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/j-j-drug-reduces-risk-of-prostate-cancer-spread-and-death-in-late-stage-study-5480024